16 May 2017 - Deborah Wilkes
Archived
GlaxoSmithKline has declined to comment on recent media reports that it is preparing to acquire the remaining 36.5% stake in its Consumer Healthcare joint venture with Novartis for around GBP8 billion (USD10 billion).
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.